HRPMF
Price:
$3.51
Market Cap:
$51.08M
Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying CDNF-based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic version of the active parent as the preclinical xCDNF candidate for the treatment of PD and other neurodegenerative diseases; and recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein that is in Phase I study in patients with PD. The company was incorporated in 2008 and is based in Espoo, Finland.
Industry
Biotechnology
IPO Date
2018-10-30
Stock Exchange
OTC
Ticker
HRPMF
According to Herantis Pharma Oyj’s latest financial reports and current stock price. The company's current Enterprise Value is 50.66M. This represents a change of 77.65% compared to the average of 28.52M of the last 4 quarters.
The mean historical Enterprise Value of Herantis Pharma Oyj over the last ten years is 26.49M. The current 50.66M Enterprise Value has changed 19.03% with respect to the historical average. Over the past ten years (40 quarters), HRPMF's Enterprise Value was at its highest in in the June 2020 quarter at 51.41M. The Enterprise Value was at its lowest in in the June 2011 quarter at 0.
Average
26.49M
Median
24.62M
Minimum
11.89M
Maximum
48.82M
Discovering the peaks and valleys of Herantis Pharma Oyj Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 65.46%
Maximum Annual Enterprise Value = 48.82M
Minimum Annual Increase = -48.33%
Minimum Annual Enterprise Value = 11.89M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 30.04M | 38.43% |
| 2023 | 21.70M | -8.38% |
| 2022 | 23.68M | 0.56% |
| 2021 | 23.55M | -7.82% |
| 2020 | 25.55M | -47.66% |
| 2019 | 48.82M | 61.36% |
| 2018 | 30.26M | 1.89% |
| 2017 | 29.69M | 50.91% |
| 2016 | 19.68M | 65.46% |
| 2015 | 11.89M | -48.33% |
The current Enterprise Value of Herantis Pharma Oyj (HRPMF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
25.14M
5-year avg
24.91M
10-year avg
26.49M
Herantis Pharma Oyj’s Enterprise Value is less than Oncopeptides AB (publ) (1.13B), less than Biostage, Inc. (57.29M), less than Mindset Pharma Inc. (66.42M), less than Goodness Growth Holdings, Inc. (128.04M), less than Abliva AB (publ) (683.00M), less than Karolinska Development AB (publ) (52.14M), less than Elegance Optical International Holdings Limited (0), greater than Relief Therapeutics Holding AG (24.49M), greater than Small Pharma Inc. (34.33M), less than SymBio Pharmaceuticals Limited (3.12B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.13B | $55.98M | |
| 57.29M | $57.82M | |
| 66.42M | $54.51M | |
| 128.04M | $61.05M | |
| 683.00M | $45.13M | |
| 52.14M | $68.85M | |
| 0 | $63.38M | |
| 24.49M | $44.94M | |
| 34.33M | $37.51M | |
| 3.12B | $30.49M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Herantis Pharma Oyj using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Herantis Pharma Oyj or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Herantis Pharma Oyj's Enterprise Value?
What is the highest Enterprise Value for Herantis Pharma Oyj (HRPMF)?
What is the 3-year average Enterprise Value for Herantis Pharma Oyj (HRPMF)?
What is the 5-year average Enterprise Value for Herantis Pharma Oyj (HRPMF)?
How does the current Enterprise Value for Herantis Pharma Oyj (HRPMF) compare to its historical average?